Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118211) titled 'Analysis of the efficacy of quadruple therapy and dual therapy in the real world for Helicobacter pylori' on Feb. 3.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Huzhou Center Hospital
Condition:
helicobacter pylori infection
Recruitment Status: Not Recruiting
Phase: Retrospective study
Date of First Enrollment: 2026-02-05
Target Sample Size: control quadruple group and Observation of the dual therapy group:2000;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=307549
Disclaimer: Curated by HT Syndication....